What weight loss agent was withdrawn from the market in 2010 for a 16% increase in myocardial infarction, non-fatal stroke, resuscitation after cardiac arrest, and cardiovascular death?
James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL; SCOUT Investigators. Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med. 2010 Sep 2;363(10):905-17. doi: 10.1056/NEJMoa1003114. PMID: 20818901.